Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Investigations – page 3

  • 79 clinical trials
  • 28 recruiting
  • 93 conditions
  • 21 countries

Conditions in this area

93 conditions with trials, the busiest first

Drug level12Human epidermal growth factor receptor negative8Fallopian tube cancer6Peritoneal cancer index6Breast cancer5Hormone receptor positive breast cancer5Allergy test4Allergy test positive3BRAF V600E mutation positive3Breast cancer female3Breast cancer metastatic3Hormone receptor positive HER2 negative breast cancer3Magnetic resonance imaging3Ovarian cancer recurrent3Colonoscopy2Cortisol abnormal2Hepatitis B e antigen negative2Hepatitis B virus test2Hypersensitivity2Infertility2Infertility female2Infertility tests normal2Non-small cell lung cancer stage IV2Ovarian cancer2+69

Clinical trials in Investigations

79 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

79 clinical trials

Electrocardiogram ST segment elevation

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Assistance Publique Hopitaux De Paris

Anti-myelin-associated glycoprotein antibodies positive

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Hospices Civils De Lyon

Eastern Cooperative Oncology Group performance status

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Karolinska University Hospital

Fallopian tube cancer+2

Recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Renal transplant

Not yet recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Tacrolimus
  • Sponsor:Oslo University Hospital HF

Cortisol abnormal

Not yet recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Hydrocortisone
  • Sponsor:Medical University Of Vienna

Paraganglion neoplasm+1

Not yet recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Assistance Publique Hopitaux De Paris

Infertility+2

Not yet recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Progesterone, Micronised
  • Sponsor:Universitair Medisch Centrum Utrecht

Allergy test positive

Not yet recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Inmunotek S.L.

Allergy test positive

Not yet recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Inmunotek S.L.

Milk allergy+1

Not yet recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Omalizumab
  • Sponsor:Hospital Infantil Universitario Nino Jesus

Magnetic resonance imaging

Not yet recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Gadoquatrane
  • Sponsor:Bayer AG

Substances studied in this area

The therapies tested most often in Investigations trials.

Sodium Chloride11 clinical trialsPaclitaxel6 clinical trialsHistamine Dihydrochloride5 clinical trialsPembrolizumab4 clinical trialsAbemaciclib3 clinical trialsCapecitabine3 clinical trialsCarboplatin3 clinical trialsDoxorubicin Hydrochloride3 clinical trialsGadobutrol3 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.